Table 3. Effect of ELAP on biochemical parameters in TAA-induced liver cirrhosis.

Treatment	Total protein (g/L)	Albumin (g/L)	Globulin (g/L)	Total bilirubin (µM)	Conjugated bilirubin (µM)
Normal control	68.67±1.4	12.83±0.70	54.5±0.22	2.7±0.21	1±0.00
TAA control	60.83±0.47#	7.83±0.16#	68.66±1.4#	9±0.21#	5.3±0.00#
Silymarin (50 mg/kg)	67.33±0.95*	11.83±0.74*	54.33±1.47*	5.6±0.76	3±0.36* #
ELAP (250 mg/kg)	61.5±0.67* #	11.66±0.21*	48±0.85* #	7±0.36* #	3.5±0.61* #
ELAP (500 mg/kg)	70±1.46*	12.16±0.30*	54.5±0.5*	5±0.77* #	3±0.22* #

Data expressed as mean ± SEM (n = 6 rats/group).

*P<0.05 compared with TAA control,

^# P<0.05 compared with normal control.